EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ceramides—Emerging Biomarkers of Lipotoxicity in Obesity, Diabetes, Cardiovascular Diseases, and Inflammation

Ginka Delcheva iD, Katya Stefanova, Teodora Stankova iD

Diseases · 23.08.2024 · 12 (9) · 195

DOI: 10.3390/diseases12090195 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 23.08.2024. Verfasst von Ginka Delcheva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormalities in lipid homeostasis have been associated with many human diseases, and the interrelation between lipotoxicity and cellular dysfunction has received significant attention in the past two decades. Ceramides (Cers) are bioactive lipid molecules that serve as precursors of all complex sphingolipids. Besides their function as structural components in cell and mitochondrial membranes, Cers play a significant role as key mediators in cell metabolism and are involved in numerous cellular processes, such as proliferation, differentiation, inflammation, and induction of apoptosis. The accumulation of various ceramides in tissues causes metabolic and cellular disturbances. Recent studies suggest that Cer lipotoxicity has an important role in obesity, metabolic syndrome, type 2 diabetes, atherosclerosis, and cardiovascular diseases (CVDs). In humans, elevated plasma ceramide levels are associated with insulin resistance and impaired cardiovascular and metabolic health. In this review, we summarize the role of ceramides as key mediators of lipotoxicity in obesity, diabetes, cardiovascular diseases, and inflammation and their potential as a promising diagnostic tool.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseasesceramidesdiabetesinflammationlipotoxicity

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.

ORCID-Profile: Ginka Delcheva, Teodora Stankova

Zitieren

APA

Delcheva, G., Stefanova, K., & Stankova, T. (2024). Ceramides—Emerging Biomarkers of Lipotoxicity in Obesity, Diabetes, Cardiovascular Diseases, and Inflammation. Diseases, 12(9), 195. https://doi.org/10.3390/diseases12090195

Vancouver

Delcheva G, Stefanova K, Stankova T. Ceramides—Emerging Biomarkers of Lipotoxicity in Obesity, Diabetes, Cardiovascular Diseases, and Inflammation. Diseases. 2024;12(9):195. doi:10.3390/diseases12090195

BibTeX
@article{Delcheva2024,
  author = {Delcheva, Ginka and Stefanova, Katya and Stankova, Teodora},
  title = {Ceramides—Emerging Biomarkers of Lipotoxicity in Obesity, Diabetes, Cardiovascular Diseases, and Inflammation},
  journal = {Diseases},
  year = {2024},
  volume = {12},
  number = {9},
  pages = {195},
  doi = {10.3390/diseases12090195}
}
Kostenlos starten →